RIL
ZBIO

Rothschild Investment LLC’s Zenas BioPharma ZBIO Stock Holding History

Rothschild Investment LLC’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508 Sell
20
-1
-5% -$20 ﹤0.01% 3262
2026
Q1 		$411 Buy
21
+20
+2,000% +$449 ﹤0.01% 3181
2025
Q4 		$36 Buy
+1
New +$33 ﹤0.01% 3295

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Rothschild Investment LLC's ZBIO Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Zenas BioPharma (ZBIO) stake by 4.8% in Q2 2026, selling an estimated $20 and leaving 20 shares worth $508. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

Rothschild Investment LLC first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Rothschild Investment LLC held 20 shares of Zenas BioPharma worth $508 as of Q2 2026.
  • Rothschild Investment LLC sold 1 Zenas BioPharma share in Q2 2026, an estimated $20.
  • Zenas BioPharma made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3262 holding.
  • Rothschild Investment LLC first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.